Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease? - Wikidata - wikimedia - TriplyDB

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?

http://www.wikidata.org/entity/Q36540902

about

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?

http://www.wikidata.org/entity/Q36540902

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?

@ast

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?

@en

type

label

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?

@ast

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?

@en

prefLabel

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?

@ast

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?

@en

P1433

Q36540902-956E2A06-E77E-456E-ACBA-179B0C8EC132

P1476

Q36540902-17A76AD6-6C40-4373-916B-93CB5ADD1669

P2093

Q36540902-4849A6E2-9B41-47EC-8B50-6370040013D5

P2860

Q36540902-3ECF5E2E-DEF5-4DB8-ACE0-7A25D9535F84

Q36540902-3FE0B5F1-2230-4F14-8DF0-9CE1AAA65D3F

Q36540902-4965125B-EB7F-46A8-9E93-A34AC876CAD8

Q36540902-53D0CA2F-EC8A-4DBE-9F4E-A1966B9F1DA9

Q36540902-A38BB412-8A47-4BCC-A51D-155B5E26E838

Q36540902-ACD4252B-4395-48DE-9B19-61C511CD035D

Q36540902-CBCCBBD2-904C-424B-BEB4-938588F17882

P304

Q36540902-351A187A-C01D-4AA6-BCC9-1BBC73D91819

P31

Q36540902-8C124993-8A89-4C0A-A560-EFBDF7395245

P356

Q36540902-26E0100A-2378-4718-A6BB-1C4E58902C00

P433

Q36540902-C694F4AE-8DD1-43D2-B52E-2AE4C7859F8E

P478

Q36540902-7E7ED1BB-E7EC-45FD-A86A-9258E9C2EFA8

P50

Q36540902-6FCA9885-9412-4132-8C00-B72BB92028BD

Q36540902-F9FFB224-7A55-4CD3-B6CA-E10DA6F2EAE3

P577

Q36540902-1D4E83CE-6F67-4F13-AEC9-57F196EDE89C

P5875

Q36540902-3D680A89-B564-4BAB-8191-9413DB5AAA51

P698

Q36540902-6B9E076A-C7C5-496D-B9B8-E87FD350E398

P932

Q36540902-89EDFCEE-5107-4344-8938-6A4858AE9AA6

P356

J.EBIOM.2015.10.013

P1433

P1476

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?

@en

P2093

Suzaan Marais

http://www.w3.org/2001/XMLSchema#string

P2860

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis.

The association between sterilizing activity and drug distribution into tuberculosis lesions.

Cerebrospinal fluid concentrations of antituberculosis agents in adults and children.

An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?

A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.

P304

1572-1573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EBIOM.2015.10.013

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Robert J. Wilkinson

P577

2015-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283956184

http://www.w3.org/2001/XMLSchema#string

P698

26870769

http://www.w3.org/2001/XMLSchema#string

P932

4740294

http://www.w3.org/2001/XMLSchema#string